about
Interventions for treating gas gangreneEffects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysisIncidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in ChinaGastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis.Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-AnalysisThe Cohort Study on Prediction of Incidence of All-Cause Mortality by Metabolic SyndromeImpact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysisCardiovascular safety and glycemic control of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus: a pairwise and network meta-analysis.Leptin and coronary heart disease: a systematic review and meta-analysis.The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review.Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort.Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients.Protein requirements in healthy adults: a meta-analysis of nitrogen balance studies
P50
Q24187236-9EFF2063-BAE0-49C8-9960-2E7258A55BC3Q27012696-1D24F08C-6A1E-4416-AA1D-F5DDC459DD51Q28478918-CFDB885B-1396-4426-9F03-A8E623941C3AQ34915090-24A4C656-496B-4145-874C-82EE2D6B287AQ35537079-EB9E7417-23D3-448A-9FC5-0D2A66D44ACCQ36011993-B169A58F-5444-4EA2-B062-1D7E195F607EQ36022142-F5D0F423-C96E-4E15-9050-D0142D5B75A5Q36520655-AE8A515B-81E5-49F1-AF96-8A08C71755D9Q38047426-648125D8-B227-448D-B53E-7A8ED0B61FB4Q38188131-6125D107-1857-4438-8AAC-09712BB45202Q38320519-41711430-9463-45B4-A0DF-8D7F84027954Q43888189-1704005B-3810-4AE5-AB3E-18B103643098Q44239925-54BD8116-D88C-4935-A9EC-62130E79CE0EQ64125163-E8AF3604-2DA6-4E32-BB12-AC050C68456C
P50
description
researcher ORCID: 0000-0001-9212-0496
@en
name
Feng Sun
@ast
Feng Sun
@en
Feng Sun
@es
Feng Sun
@nl
type
label
Feng Sun
@ast
Feng Sun
@en
Feng Sun
@es
Feng Sun
@nl
prefLabel
Feng Sun
@ast
Feng Sun
@en
Feng Sun
@es
Feng Sun
@nl
P106
P31
P496
0000-0001-9212-0496